Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease.

A new study highlights the increasing dangers of childhood chemical exposure and how even small exposures can lead to serious ...

Climate change is impacting the spread of Salmonella, according to new research from the University of Surrey.

Active management after concussion is the best way for patients to recover and get back to school and work as quickly as ...

AstraZeneca (AZN) and Daiichi Sankyo’s ENHERTU has been approved in the US for the treatment of adult patients with unresectable or metastatic ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...

A team of researchers has developed a new scoring system for a nationwide scheme, overseen by the Advisory Committee on Clinical Impact Awards (ACCIA), to recognise and reward senior doctors and ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in the U.S. is expected to double by 2060.